fda semaglutide news approves first-ever oral GLP-1RA for obesity and chronic weight management. Meet Wegovy (semaglutide) tablets. https://www.prnewswire.com/ news-releases/fda-approves-novo-nordisks-wegovy-pill-the-first-and-only-oral-glp-1-for-weight-loss-in-adults 🎉Exciting news that Semaglutide is

Currently, semaglutide is considered one of the most effective anti-obesity interventions, with some scientists describing the United States Food and Drug Administration (FDA) approval of this drug as a "paradigm shift" in anti-obesity treatment

Many patients can lose a substantial amount of weight often 10% or more of their body weight in a year which can improve diabetes control and other health markers

But now Mark's main focus is, I asked him if he was going to write another book

Host-gut microbiota metabolic interactions

Moreover, several cardiovascular trials have demonstrated a reduced risk of adverse cardiovascular events among type 2 diabetes patients with CVD or high cardiovascular risk who were treated with GLP-1RAs [10]

Glycerin enhances moisture retention and improves comfort